The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000020.3(ACVRL1):c.293A>G (p.Asn98Ser)

CA384898102

426011 (ClinVar)

Gene: ACVRL1 (HGNC:94)
Condition: telangiectasia, hereditary hemorrhagic, type 2 (MONDO:0010880)
Inheritance Mode: Autosomal dominant inheritance
UUID: ccc50676-c1fa-40ab-a808-bc0676b7e7de
Approved on: 2025-12-12
Published on: 2025-12-28

HGVS expressions

NM_000020.3:c.293A>G
NM_000020.3(ACVRL1):c.293A>G (p.Asn98Ser)
NC_000012.12:g.51913330A>G
CM000674.2:g.51913330A>G
NC_000012.11:g.52307114A>G
CM000674.1:g.52307114A>G
NC_000012.10:g.50593381A>G
NG_009549.1:g.10913A>G
ENST00000547400.6:c.335A>G
ENST00000551576.6:c.293A>G
ENST00000552678.2:c.293A>G
ENST00000388922.9:c.293A>G
ENST00000388922.8:c.293A>G
ENST00000419526.6:c.103+795A>G
ENST00000547400.5:c.335A>G
ENST00000550683.5:c.335A>G
NM_000020.2:c.293A>G
NM_001077401.1:c.293A>G
NM_001077401.2:c.293A>G
More

Likely Pathogenic

Met criteria codes 3
PS4 PM2_Supporting PS3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Hemorrhagic Telangiectasia Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ACVRL1 Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Hemorrhagic Telangiectasia VCEP
The NM_000020.3: c.293A>G variant in ACVRL1 is a missense variant predicted to cause substitution of asparagine by serine at amino acid 98 (p.Asn98Ser). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.508, which is neither above nor below the thresholds predicting a damaging or benign impact on ACVRL1 function. Functional assays showed the variant protein to be non-functional (PS3_Supporting; Internal lab contributors). This variant has been reported in 5 probands with a phenotype consistent with HHT (PS4_Strong; PMIDs: 16690726, 18498373, Internal lab contributors). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel. Approved by Expert Panel:12/12/2025. Evidence used: PS4_Strong, PM2_Supporting, PS3_Supporting (specification version 1.1.0; 12/12/2025).
Met criteria codes
PS4
This variant has been reported in 5 probands with a phenotype consistent with HHT (PS4_Strong; PMIDs: 16690726, 18498373, Internal lab contributors).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PS3_Supporting
Functional assays showed the variant protein to be non-functional (PS3_Supporting; Internal lab contributors).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.